Pharmaniaga Berhad Dividend
Dividend criteria checks 0/6
Pharmaniaga Berhad does not currently pay a dividend.
Key information
0%
Dividend yield
0%
Payout ratio
Industry average yield | 1.8% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -RM0.054 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
Recent updates
Pharmaniaga Berhad (KLSE:PHARMA) Shares Could Be 49% Below Their Intrinsic Value Estimate
Apr 19Insufficient Growth At Pharmaniaga Berhad (KLSE:PHARMA) Hampers Share Price
Oct 03Is There An Opportunity With Pharmaniaga Berhad's (KLSE:PHARMA) 37% Undervaluation?
Jul 19Is It Too Late To Consider Buying Pharmaniaga Berhad (KLSE:PHARMA)?
Feb 18Many Would Be Envious Of Pharmaniaga Berhad's (KLSE:PHARMA) Excellent Returns On Capital
Dec 10Bullish: Analysts Just Made A Massive Upgrade To Their Pharmaniaga Berhad (KLSE:PHARMA) Forecasts
Nov 24We Think That There Are Issues Underlying Pharmaniaga Berhad's (KLSE:PHARMA) Earnings
Aug 27Pharmaniaga Berhad (KLSE:PHARMA) Has A Somewhat Strained Balance Sheet
May 28Should You Buy Pharmaniaga Berhad (KLSE:PHARMA) For Its 1.8% Dividend?
Mar 15Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if PHARMA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PHARMA's dividend payments have been increasing.
Dividend Yield vs Market
Pharmaniaga Berhad Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (PHARMA) | 0% |
Market Bottom 25% (MY) | 1.9% |
Market Top 25% (MY) | 4.6% |
Industry Average (Healthcare) | 1.8% |
Analyst forecast in 3 Years (PHARMA) | 0% |
Notable Dividend: Unable to evaluate PHARMA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PHARMA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: PHARMA is not paying a notable dividend for the MY market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PHARMA has not reported any payouts.